Settlement Reached In Patent Dispute Over Enzyme Blends

Law360, New York (May 12, 2006, 12:00 AM EDT) -- In a development that ends several long-running patent disputes, Takara Bio Inc. and Stratagene Corporation have reached an agreement pertaining to enzyme blends used in polymerase chain reaction, or P.C.R., technology.

The companies had been doing battle in a Maryland federal court as well as the U.S. Trademark and Patent office.

La Jolla, California-based Stratagene Corp. and Takara Bio—which is headquartered in Shiga, Japan—nipped potential future conflicts in the bud by putting in place a cross-licensing deal for the patents in question. The only payments involved...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.